Cargando…

Molecular-Targeted Therapies for Hematologic Malignancies

Detalles Bibliográficos
Autores principales: Bunting, Kevin D., Qu, Cheng-Kui, Tomasson, Michael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254001/
https://www.ncbi.nlm.nih.gov/pubmed/22242021
http://dx.doi.org/10.1155/2012/606423
_version_ 1782220790826008576
author Bunting, Kevin D.
Qu, Cheng-Kui
Tomasson, Michael H.
author_facet Bunting, Kevin D.
Qu, Cheng-Kui
Tomasson, Michael H.
author_sort Bunting, Kevin D.
collection PubMed
description
format Online
Article
Text
id pubmed-3254001
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-32540012012-01-12 Molecular-Targeted Therapies for Hematologic Malignancies Bunting, Kevin D. Qu, Cheng-Kui Tomasson, Michael H. Adv Hematol Editorial Hindawi Publishing Corporation 2012 2011-12-28 /pmc/articles/PMC3254001/ /pubmed/22242021 http://dx.doi.org/10.1155/2012/606423 Text en Copyright © 2012 Kevin D. Bunting et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Bunting, Kevin D.
Qu, Cheng-Kui
Tomasson, Michael H.
Molecular-Targeted Therapies for Hematologic Malignancies
title Molecular-Targeted Therapies for Hematologic Malignancies
title_full Molecular-Targeted Therapies for Hematologic Malignancies
title_fullStr Molecular-Targeted Therapies for Hematologic Malignancies
title_full_unstemmed Molecular-Targeted Therapies for Hematologic Malignancies
title_short Molecular-Targeted Therapies for Hematologic Malignancies
title_sort molecular-targeted therapies for hematologic malignancies
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254001/
https://www.ncbi.nlm.nih.gov/pubmed/22242021
http://dx.doi.org/10.1155/2012/606423
work_keys_str_mv AT buntingkevind moleculartargetedtherapiesforhematologicmalignancies
AT quchengkui moleculartargetedtherapiesforhematologicmalignancies
AT tomassonmichaelh moleculartargetedtherapiesforhematologicmalignancies